Skip to main content
TipRanks
Go Ultimate75% OFF

Sriram Ryali Insider Profile

11 Followers

Sriram Ryali, CFO at Caribou Biosciences, holds 72.36K shares in Caribou Biosciences (Ticker: CRBU), holds 175.79K shares in Codexis (Ticker: CDXS), holds 41.57K shares in Eiger Biopharmaceuticals (Ticker: EIGRQ).

Sriram Ryali's Trading History

CRBU
Caribou Biosciences
Feb 20, 2026CFOUninformative Buy―$26.12K
CDXS
Codexis
Jan 02, 2024CFOUninformative Buy―$203.92K
EIGRQ
Eiger Biopharmaceuticals
Mar 14, 2022―Informative Sell12.67K$353.31K

You May Also Like

Sriram Ryali insider profile FAQ

What is the percentage of profitable transactions made by Sriram Ryali?
The percentage of profitable transactions made by Sriram Ryali is 75%.
What is the average return per transaction made by Sriram Ryali?
The average return per transaction made by Sriram Ryali is 27.40%.
What stocks does Sriram Ryali hold?
Sriram Ryali holds: CRBU, CDXS, EIGRQ stocks.
What was Sriram Ryali's most profitable transaction?
Sriram Ryali’s most profitable transaction was an Informative Sell of EIGRQ stock on March 14, 2022. The return on the trade was 77.70%.
What is Sriram Ryali's role in Caribou Biosciences?
Sriram Ryali's role in Caribou Biosciences is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.